A Chart Review of Cyproheptadine for Stimulant-Induced Weight Loss

Journal of Child and Adolescent Psychopharmacology

Volumn 14, Issue 1, 2004, Pages 65-73

  Daviss, W Burleson ^a   Scott, John ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; CYPROHEPTADINE; METHYLPHENIDATE; OROS;

ADOLESCENT; ANOREXIA; ATTENTION DEFICIT DISORDER; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; DRY NOSE; EPISTAXIS; FACE EDEMA; HEADACHE; HUMAN; INSOMNIA; MEDICAL RECORD; NOSE MUCOSA; OUTPATIENT; PRESCRIPTION; REVIEW; SEDATION; SIDE EFFECT; WEIGHT REDUCTION;

ADOLESCENT; ANTI-OBESITY AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; CYPROHEPTADINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 1942539157     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454604773840508     Document Type: Review

References (31)

1. Aizenberg D, Zemishlany Z, Weizman A: Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 18:320-324, 1995.
2. Bairagi R: A comparison of five anthropometric indices for identifying factors of malnutrition. Am J Epidemiol 126:258-267, 1987.
3. Bergren SS: Appetite stimulating properties of cyproheptadine. Am Dis Child 108:270-273, 1964.
4. Chakrabarty AS, Pillai RV, Anand BK, Singh B: Effect of cyproheptadine on the electrical activity of the hypothalamic feeding centers. Brain Res 6:561-569, 1967.
5. Corkum P, Rimer P, Schachar R: Parental knowledge of attention-deficit hyperactivity disorder and opinions of treatment options: Impact on enrollment and adherence to a 12-month treatment trial. Can J Psychiatry 44:1043-1048, 1999.
6. Corkum P, Tannock R, Moldofsky H: Sleep disturbances in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 37:637-646, 1998.
7. Costello AJ, Benjamin R, Angold A, Silver D: Mood variability in adolescents: A study of depressed, nondepressed and comorbid patients. J Affect Disord 23:199-212, 1991.
8. Dahl RE, Pelham WE, Wierson M: The role of sleep disturbances in attention deficit disorder symptoms: A case study. J Pediatr Psychol 16:229-239, 1991.
9. Day HD, Abmayr SB: Parent reports of sleep disturbances in stimulant-medicated children with attention-deficit hyperactivity disorder. J Clin Psychol 54:701-716, 1998.
10. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R: ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, Guilford, 1998.
11. Firestone P: Factors associated with children's adherence to stimulant medication. Am J Orthopsychiatry 52:447-457, 1982.
12. Goldberg SC, Halmi KA, Eckert ED, Casper RC, Davis JM: Cyproheptadine in anorexia nervosa. Br J Psychiatry 134:67-70, 1979.
13. Greenhill LL, Pliszka SR, Dulcan MK, Bennet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S: Practice parameters for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41:26-49, 2002.
14. Gupta S, Austin R, Cali LA, Bhatara V: Nightmares treated with cyproheptadine. J Am Acad Child Adolesc Psychiatry 37:570-571, 1998.
15. Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville (Maryland), U.S. Department of Health, Education and Welfare, 1976.
16. Kaplowitz PB, Jennings S: Enhancement of linear growth and weight gain by cyproheptadine in children with hypopituitarism receiving growth hormone therapy. J Pediatr 110:140-143, 1987.
17. Loney J, Millich R: Hyperactivity, inattention and aggression in clinical practice. In: Advances in Developmental and Behavioral Pediatrics. Edited by Routh DK. Greenwich (Connecticut), AB Press, 1982, pp 113-147.
18. Mick E, Biederman J, Jetton J, Faraone SV: Sleep disturbances associated with attention deficit hyperactivity disorder: The impact of psychiatric comorbidity and pharmacotherapy. J Child Adolesc Psychopharmacol 10:223-231, 2000.
19. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 56:1073-1086, 1999.
20. Physicians' Desk Reference: Periactin tablets (Cyproheptadine HC1). In: Physicians' Desk Reference, 56th edition. Edited by Gwynned LK. Montvale (New Jersey), Medical Economics, Inc., 2002, pp 2155-2156.
21. Peroutka SJ, Allen GS: The calcium antagonist properties of cyproheptadine: Implications for antimigraine action. Neurology 34:304-309, 1984.
22. Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, McCracken JT, Swanson JM, Hughes CW, Llana ME, Lopez M, Toprac MG: The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. J Am Acad Child Adolesc Psychiatry 39:920-927, 2000.
23. Rubinstein S, Silver LB, Licamele WL: Clonidine for stimulant-related sleep problems. J Am Acad Child Adolesc Psychiatry 33:281-282, 1994.
24. Sanzgiri RR, Mohamad HA, Raja Z: Appetite stimulation and weight gain with cyproheptadine. A double-blind study in underweight children. J Postgrad Med 16:12-15, 1970.
25. Siberry GK: Growth charts. In: The Harriet Lane Handbook, 15th ed. Edited by Siberry GK, Iannone R. St. Louis, Mosby, Inc., 2000, pp 283-306.
26. Stein MA: Unravelling sleep problems in treated and untreated children with ADHD. J Child Adolesc Psychopharmacol 9:157-168, 1999.
27. Thiruchelvam D, Charach A, Schachar RJ: Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry 40:922-928, 2001.
28. Vitiello B, Severe JB, Greenhill LL, Arnold LE, Abikoff HB, Bukstein OG, Elliott GR, Hechtman L, Jensen PS, Hinshaw SP, March JS, Newcom JH, Swanson JM, Cantwell DP: Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA. J Am Acad Child Adolesc Psychiatry 40:188-196, 2001.
29. Wilens TE, Biederman J: The stimulants. Psychiatr Clin North Am 15:191-222, 1992.
30. Wilens TE, Spencer TJ: The stimulants revisited. Child Adolesc Psychiatr Clin N Am 9:573-603, 2000.
31. Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G: Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/ hyperactivity disorder. Pediatrics 108:883-892, 2001.